Lucile Packard Children's Hospital
Palo Alto, California, 94304, United States
NCT Number: NCT01696331
Text message reminders will improve adherence to lab tests in adolescent liver transplant recipients.
Looking for future studies?
Notify Me12 year–25 year
All sexes
Interventional
Not applicable
Palo Alto, California, 94304, United States
Adolescent patients who received a liver transplant will be recruited to participate in receiving text message reminders for lab tests. They will be send de-identified messages according to their required lab schedule. The investigators will monitor their adherence to lab tests as well as medication and clinic visits. They will also have a questionnaire about their medical regimen before and at the end of the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Sent TM reminder at beginning and end of each month that corresponded to required lab frequency. Patients were able to send autoresponses.
Time frame: One year
Time frame: 1 year
Correspondence between actual completion of tests versus reported
Stanford University
Other
Impact of Text Messaging on Adherence in Adolescent Liver Transplant Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05506878
Abdominal Pain, Agnosia
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT07701031
Digestive System Diseases, Fibrosis
Münster, Germany
View Trial DetailsNCT06635564
Bleeding Disorder, Brain Diseases
Vienna, Austria
View Trial DetailsNCT04836923
Cirrhosis, Fibrosis
Chicago, Illinois, United States
View Trial Details